

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.66570578 |
| 2 | hemidesmosome assembly (GO:0031581) | 5.67587224 |
| 3 | thrombin receptor signaling pathway (GO:0070493) | 5.37851692 |
| 4 | desmosome organization (GO:0002934) | 4.99708423 |
| 5 | establishment of skin barrier (GO:0061436) | 4.90310750 |
| 6 | regulation of platelet aggregation (GO:0090330) | 4.56495718 |
| 7 | lipoxygenase pathway (GO:0019372) | 4.50997132 |
| 8 | regulation of water loss via skin (GO:0033561) | 4.50044708 |
| 9 | keratinization (GO:0031424) | 4.46564439 |
| 10 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.40114369 |
| 11 | neutrophil activation (GO:0042119) | 4.31357594 |
| 12 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.24585705 |
| 13 | platelet aggregation (GO:0070527) | 4.21109427 |
| 14 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.16391874 |
| 15 | angiogenesis involved in wound healing (GO:0060055) | 4.12692485 |
| 16 | positive regulation of mast cell activation (GO:0033005) | 4.06647103 |
| 17 | regulation of platelet activation (GO:0010543) | 4.04897119 |
| 18 | granulocyte activation (GO:0036230) | 3.97873067 |
| 19 | adenosine receptor signaling pathway (GO:0001973) | 3.88482258 |
| 20 | mesodermal cell differentiation (GO:0048333) | 3.84528901 |
| 21 | regulation of integrin activation (GO:0033623) | 3.80481612 |
| 22 | positive regulation of receptor recycling (GO:0001921) | 3.72173585 |
| 23 | cell-substrate junction assembly (GO:0007044) | 3.70780440 |
| 24 | hypotonic response (GO:0006971) | 3.60561232 |
| 25 | protein neddylation (GO:0045116) | 3.58688735 |
| 26 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.55738008 |
| 27 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.47799529 |
| 28 | negative regulation of platelet activation (GO:0010544) | 3.42321783 |
| 29 | negative regulation of interleukin-17 production (GO:0032700) | 3.41466205 |
| 30 | homotypic cell-cell adhesion (GO:0034109) | 3.27433032 |
| 31 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.26969026 |
| 32 | keratinocyte differentiation (GO:0030216) | 3.26753773 |
| 33 | megakaryocyte development (GO:0035855) | 3.26599739 |
| 34 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.25371600 |
| 35 | platelet degranulation (GO:0002576) | 3.21232101 |
| 36 | detection of other organism (GO:0098543) | 3.20090705 |
| 37 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.18926486 |
| 38 | peptide cross-linking (GO:0018149) | 3.16942491 |
| 39 | regulation of mast cell degranulation (GO:0043304) | 3.14795606 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.13779976 |
| 41 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.13611892 |
| 42 | detection of bacterium (GO:0016045) | 3.09515198 |
| 43 | regulation of leukocyte degranulation (GO:0043300) | 3.06812691 |
| 44 | protein localization to endosome (GO:0036010) | 3.06715626 |
| 45 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.00072310 |
| 46 | negative regulation of stress fiber assembly (GO:0051497) | 2.99355638 |
| 47 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.96224362 |
| 48 | positive regulation of macrophage differentiation (GO:0045651) | 2.94189850 |
| 49 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.93668374 |
| 50 | regulation of mast cell activation (GO:0033003) | 2.93436561 |
| 51 | fatty acid elongation (GO:0030497) | 2.93035857 |
| 52 | platelet formation (GO:0030220) | 2.90734981 |
| 53 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.90450292 |
| 54 | platelet activation (GO:0030168) | 2.89802129 |
| 55 | positive regulation of blood coagulation (GO:0030194) | 2.89346854 |
| 56 | positive regulation of hemostasis (GO:1900048) | 2.89346854 |
| 57 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.87908915 |
| 58 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.84504066 |
| 59 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.84504066 |
| 60 | modulation by symbiont of host immune response (GO:0052553) | 2.84504066 |
| 61 | positive regulation by symbiont of host defense response (GO:0052509) | 2.84504066 |
| 62 | modulation by symbiont of host defense response (GO:0052031) | 2.84504066 |
| 63 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.84504066 |
| 64 | leukocyte degranulation (GO:0043299) | 2.82920868 |
| 65 | response to peptidoglycan (GO:0032494) | 2.81179024 |
| 66 | positive regulation of leukocyte degranulation (GO:0043302) | 2.78193491 |
| 67 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.78095424 |
| 68 | positive regulation of hair follicle development (GO:0051798) | 2.76827774 |
| 69 | positive regulation of hair cycle (GO:0042635) | 2.76827774 |
| 70 | purinergic receptor signaling pathway (GO:0035587) | 2.72793361 |
| 71 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.71635411 |
| 72 | myeloid cell activation involved in immune response (GO:0002275) | 2.71469216 |
| 73 | positive regulation of coagulation (GO:0050820) | 2.71019935 |
| 74 | hepatocyte apoptotic process (GO:0097284) | 2.69835826 |
| 75 | epithelial cell-cell adhesion (GO:0090136) | 2.69524301 |
| 76 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.69400134 |
| 77 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.69092343 |
| 78 | endothelium development (GO:0003158) | 2.68989176 |
| 79 | blood coagulation, intrinsic pathway (GO:0007597) | 2.65834800 |
| 80 | regulation of interleukin-17 production (GO:0032660) | 2.65764225 |
| 81 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.64138902 |
| 82 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.63393802 |
| 83 | phagocytosis, engulfment (GO:0006911) | 2.62698289 |
| 84 | peptide catabolic process (GO:0043171) | 2.62532771 |
| 85 | extracellular fibril organization (GO:0043206) | 2.61954261 |
| 86 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.59967075 |
| 87 | multicellular organismal water homeostasis (GO:0050891) | 2.59827435 |
| 88 | positive regulation of mast cell degranulation (GO:0043306) | 2.59197618 |
| 89 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.59197618 |
| 90 | fibril organization (GO:0097435) | 2.59170702 |
| 91 | keratinocyte proliferation (GO:0043616) | 2.54920885 |
| 92 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.54615598 |
| 93 | integrin-mediated signaling pathway (GO:0007229) | 2.52213845 |
| 94 | negative regulation of protein localization to cell surface (GO:2000009) | 2.49965588 |
| 95 | histamine transport (GO:0051608) | 2.49596940 |
| 96 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.49148717 |
| 97 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.48623267 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.48623267 |
| 99 | regulation of early endosome to late endosome transport (GO:2000641) | 2.48473729 |
| 100 | epidermal cell differentiation (GO:0009913) | 2.46190375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.01602556 |
| 2 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.83441299 |
| 3 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.82470908 |
| 4 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58562896 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.55695343 |
| 6 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.55476869 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.47214844 |
| 8 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.42553961 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.41188331 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.40590992 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.36999294 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.35619917 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26123606 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20131922 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.17133508 |
| 16 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.16228068 |
| 17 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.16228068 |
| 18 | SPI1_23127762_ChIP-Seq_K562_Human | 2.13113912 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.12075016 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11389886 |
| 21 | GATA1_19941826_ChIP-Seq_K562_Human | 2.09157518 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08933514 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.08159285 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.97634516 |
| 25 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.95981904 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.92413690 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89557311 |
| 28 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.89021124 |
| 29 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.87057149 |
| 30 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.84307528 |
| 31 | GATA2_19941826_ChIP-Seq_K562_Human | 1.83444239 |
| 32 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.81895367 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.78241162 |
| 34 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.77630741 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76009984 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74222327 |
| 37 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.69537447 |
| 38 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.63626146 |
| 39 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60120861 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59473469 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.55727151 |
| 42 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.52776035 |
| 43 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.52554630 |
| 44 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.49822191 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.49452714 |
| 46 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45437860 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44785036 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43820806 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43320901 |
| 50 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.40628028 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37958547 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37742752 |
| 53 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35956651 |
| 54 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.34703971 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34590128 |
| 56 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34563924 |
| 57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32347024 |
| 58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.27923709 |
| 59 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.26845068 |
| 60 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24314996 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22254577 |
| 62 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19529791 |
| 63 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.19079591 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18419909 |
| 65 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18183621 |
| 66 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16883224 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14384686 |
| 68 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13997142 |
| 69 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13690257 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.13001478 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12635816 |
| 72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12589420 |
| 73 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.12311649 |
| 74 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11601738 |
| 75 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.08806337 |
| 76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07961602 |
| 77 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07357455 |
| 78 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.07189439 |
| 79 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.05952886 |
| 80 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05388582 |
| 81 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.04896102 |
| 82 | UTX_26944678_Chip-Seq_JUKART_Human | 1.04399036 |
| 83 | MAF_26560356_Chip-Seq_TH1_Human | 1.04298079 |
| 84 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02619206 |
| 85 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02331203 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01245184 |
| 87 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00737948 |
| 88 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99664574 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99649083 |
| 90 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99257298 |
| 91 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96464898 |
| 92 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95964451 |
| 93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95602332 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92899039 |
| 95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92805208 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.91747754 |
| 97 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.91099387 |
| 98 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90372067 |
| 99 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.89146220 |
| 100 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87827726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 5.91881618 |
| 2 | MP0003566_abnormal_cell_adhesion | 3.94085866 |
| 3 | MP0008004_abnormal_stomach_pH | 3.62467294 |
| 4 | MP0002796_impaired_skin_barrier | 3.62141745 |
| 5 | MP0000579_abnormal_nail_morphology | 3.31029506 |
| 6 | MP0003724_increased_susceptibility_to | 3.03948717 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.00778074 |
| 8 | MP0000465_gastrointestinal_hemorrhage | 2.89436048 |
| 9 | MP0003453_abnormal_keratinocyte_physiol | 2.72088272 |
| 10 | MP0005501_abnormal_skin_physiology | 2.63800926 |
| 11 | MP0004947_skin_inflammation | 2.40024023 |
| 12 | MP0004510_myositis | 2.32774715 |
| 13 | MP0003303_peritoneal_inflammation | 2.30068927 |
| 14 | MP0005275_abnormal_skin_tensile | 2.20158779 |
| 15 | MP0003828_pulmonary_edema | 2.12412952 |
| 16 | MP0003436_decreased_susceptibility_to | 2.09671261 |
| 17 | MP0005409_darkened_coat_color | 2.05456546 |
| 18 | MP0001851_eye_inflammation | 1.94858902 |
| 19 | MP0010678_abnormal_skin_adnexa | 1.94490073 |
| 20 | MP0001216_abnormal_epidermal_layer | 1.93716860 |
| 21 | MP0005023_abnormal_wound_healing | 1.90365177 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.88589554 |
| 23 | MP0000858_altered_metastatic_potential | 1.85953324 |
| 24 | MP0004381_abnormal_hair_follicle | 1.85312385 |
| 25 | MP0000383_abnormal_hair_follicle | 1.78139533 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.77302745 |
| 27 | MP0000467_abnormal_esophagus_morphology | 1.75384287 |
| 28 | MP0005083_abnormal_biliary_tract | 1.73037812 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.71689646 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 1.67388690 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.65916817 |
| 32 | MP0008260_abnormal_autophagy | 1.64706184 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.61889728 |
| 34 | MP0001849_ear_inflammation | 1.55135967 |
| 35 | MP0004264_abnormal_extraembryonic_tissu | 1.54597782 |
| 36 | MP0010352_gastrointestinal_tract_polyps | 1.54184160 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.48444907 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.46899753 |
| 39 | MP0000343_altered_response_to | 1.46031344 |
| 40 | MP0010771_integument_phenotype | 1.45390785 |
| 41 | MP0002060_abnormal_skin_morphology | 1.40385110 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.38835270 |
| 43 | MP0002098_abnormal_vibrissa_morphology | 1.38022094 |
| 44 | MP0004272_abnormal_basement_membrane | 1.35540815 |
| 45 | MP0002419_abnormal_innate_immunity | 1.32119240 |
| 46 | MP0004084_abnormal_cardiac_muscle | 1.31869433 |
| 47 | MP0005000_abnormal_immune_tolerance | 1.27741819 |
| 48 | MP0003091_abnormal_cell_migration | 1.21774935 |
| 49 | MP0009053_abnormal_anal_canal | 1.20870942 |
| 50 | MP0003638_abnormal_response/metabolism_ | 1.19256226 |
| 51 | MP0000377_abnormal_hair_follicle | 1.11606670 |
| 52 | MP0002452_abnormal_antigen_presenting | 1.10091903 |
| 53 | MP0005025_abnormal_response_to | 1.08690480 |
| 54 | MP0009931_abnormal_skin_appearance | 1.08094716 |
| 55 | MP0002723_abnormal_immune_serum | 1.05346341 |
| 56 | MP0003075_altered_response_to | 1.04154579 |
| 57 | MP0000249_abnormal_blood_vessel | 1.03797174 |
| 58 | MP0004883_abnormal_blood_vessel | 1.03625118 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 1.00445078 |
| 60 | MP0001790_abnormal_immune_system | 0.99640456 |
| 61 | MP0005387_immune_system_phenotype | 0.99640456 |
| 62 | MP0000685_abnormal_immune_system | 0.98928783 |
| 63 | MP0002998_abnormal_bone_remodeling | 0.98575497 |
| 64 | MP0003941_abnormal_skin_development | 0.96700828 |
| 65 | MP0001819_abnormal_immune_cell | 0.96070613 |
| 66 | MP0002420_abnormal_adaptive_immunity | 0.96050046 |
| 67 | MP0000762_abnormal_tongue_morphology | 0.95356259 |
| 68 | MP0001800_abnormal_humoral_immune | 0.94312878 |
| 69 | MP0003448_altered_tumor_morphology | 0.93570835 |
| 70 | MP0005164_abnormal_response_to | 0.93282838 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 0.92742351 |
| 72 | MP0002398_abnormal_bone_marrow | 0.90828285 |
| 73 | MP0005165_increased_susceptibility_to | 0.87753057 |
| 74 | MP0006054_spinal_hemorrhage | 0.85698220 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 0.82261841 |
| 76 | MP0001545_abnormal_hematopoietic_system | 0.82261841 |
| 77 | MP0002132_abnormal_respiratory_system | 0.81696404 |
| 78 | MP0001845_abnormal_inflammatory_respons | 0.81500838 |
| 79 | MP0009764_decreased_sensitivity_to | 0.81427887 |
| 80 | MP0009333_abnormal_splenocyte_physiolog | 0.80837437 |
| 81 | MP0005666_abnormal_adipose_tissue | 0.79438334 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 0.79381851 |
| 83 | MP0001663_abnormal_digestive_system | 0.79202348 |
| 84 | MP0009763_increased_sensitivity_to | 0.78659712 |
| 85 | MP0001191_abnormal_skin_condition | 0.78515982 |
| 86 | MP0005671_abnormal_response_to | 0.76236721 |
| 87 | MP0003045_fibrosis | 0.76214887 |
| 88 | MP0005390_skeleton_phenotype | 0.74737812 |
| 89 | MP0000230_abnormal_systemic_arterial | 0.74116536 |
| 90 | MP0004130_abnormal_muscle_cell | 0.73501730 |
| 91 | MP0009785_altered_susceptibility_to | 0.73036555 |
| 92 | MP0010368_abnormal_lymphatic_system | 0.72945546 |
| 93 | MP0002429_abnormal_blood_cell | 0.72404887 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.71735675 |
| 95 | MP0000490_abnormal_crypts_of | 0.70281904 |
| 96 | MP0006138_congestive_heart_failure | 0.69405571 |
| 97 | MP0000716_abnormal_immune_system | 0.68663728 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.67157336 |
| 99 | MP0008874_decreased_physiological_sensi | 0.65227223 |
| 100 | MP0003763_abnormal_thymus_physiology | 0.62984697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 7.79485305 |
| 2 | Menorrhagia (HP:0000132) | 7.43619188 |
| 3 | Increased mean platelet volume (HP:0011877) | 7.38833910 |
| 4 | Abnormal platelet volume (HP:0011876) | 7.12982208 |
| 5 | Petechiae (HP:0000967) | 6.56008948 |
| 6 | Purpura (HP:0000979) | 5.85916225 |
| 7 | Epistaxis (HP:0000421) | 5.46156565 |
| 8 | Abnormality of nail color (HP:0100643) | 4.96346924 |
| 9 | Gingival bleeding (HP:0000225) | 4.92810865 |
| 10 | Thick nail (HP:0001805) | 4.72599642 |
| 11 | Impaired platelet aggregation (HP:0003540) | 4.22516979 |
| 12 | Abnormal platelet function (HP:0011869) | 4.22516979 |
| 13 | Onycholysis (HP:0001806) | 4.20384864 |
| 14 | Plantar hyperkeratosis (HP:0007556) | 4.19620204 |
| 15 | Milia (HP:0001056) | 4.03022556 |
| 16 | Palmoplantar hyperkeratosis (HP:0000972) | 3.69470398 |
| 17 | Fragile nails (HP:0001808) | 3.67283848 |
| 18 | Alopecia of scalp (HP:0002293) | 3.59736130 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.48542600 |
| 20 | Palmar hyperkeratosis (HP:0010765) | 3.42624080 |
| 21 | Increased IgE level (HP:0003212) | 3.29478311 |
| 22 | Nail dystrophy (HP:0008404) | 3.27257027 |
| 23 | Right ventricular cardiomyopathy (HP:0011663) | 3.22721502 |
| 24 | Abnormality of macrophages (HP:0004311) | 2.98313192 |
| 25 | Eczematoid dermatitis (HP:0000976) | 2.93617905 |
| 26 | Hyperlipoproteinemia (HP:0010980) | 2.88399973 |
| 27 | Bruising susceptibility (HP:0000978) | 2.85398006 |
| 28 | Abnormal blistering of the skin (HP:0008066) | 2.83944408 |
| 29 | Erythema (HP:0010783) | 2.73901690 |
| 30 | Oral leukoplakia (HP:0002745) | 2.73767211 |
| 31 | Atrophic scars (HP:0001075) | 2.67947836 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 2.67412201 |
| 33 | Ridged nail (HP:0001807) | 2.58638993 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 2.46387733 |
| 35 | Hypotrichosis (HP:0001006) | 2.40654392 |
| 36 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.32666836 |
| 37 | Hepatosplenomegaly (HP:0001433) | 2.26951575 |
| 38 | Pustule (HP:0200039) | 2.26465064 |
| 39 | Distal lower limb amyotrophy (HP:0008944) | 2.25417165 |
| 40 | Corneal erosion (HP:0200020) | 2.21123082 |
| 41 | Ankyloglossia (HP:0010296) | 2.19115183 |
| 42 | Acanthocytosis (HP:0001927) | 2.18178038 |
| 43 | Pili torti (HP:0003777) | 2.15808490 |
| 44 | Recurrent abscess formation (HP:0002722) | 2.14655061 |
| 45 | Distal lower limb muscle weakness (HP:0009053) | 2.10862644 |
| 46 | Conjunctival telangiectasia (HP:0000524) | 2.05445749 |
| 47 | Increased density of long bones (HP:0006392) | 2.05279235 |
| 48 | Lip pit (HP:0100267) | 2.04193940 |
| 49 | Stomatitis (HP:0010280) | 2.02107807 |
| 50 | Urticaria (HP:0001025) | 2.01368632 |
| 51 | Dyschromatopsia (HP:0007641) | 2.00963094 |
| 52 | Abnormality of oral frenula (HP:0000190) | 2.00283819 |
| 53 | Poikilocytosis (HP:0004447) | 1.99765510 |
| 54 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.99156038 |
| 55 | Woolly hair (HP:0002224) | 1.96833273 |
| 56 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.95160533 |
| 57 | Erythroderma (HP:0001019) | 1.93595142 |
| 58 | Abnormal auditory evoked potentials (HP:0006958) | 1.92228793 |
| 59 | Paralysis (HP:0003470) | 1.89867685 |
| 60 | Aplasia cutis congenita (HP:0001057) | 1.85157776 |
| 61 | Hypoplasia of dental enamel (HP:0006297) | 1.84507316 |
| 62 | Abnormal pupillary function (HP:0007686) | 1.80039101 |
| 63 | Skin ulcer (HP:0200042) | 1.79161424 |
| 64 | Gangrene (HP:0100758) | 1.77129669 |
| 65 | Increased IgM level (HP:0003496) | 1.75861592 |
| 66 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.74407976 |
| 67 | Abnormality of iron homeostasis (HP:0011031) | 1.74324764 |
| 68 | Interstitial pulmonary disease (HP:0006530) | 1.73227283 |
| 69 | Sparse scalp hair (HP:0002209) | 1.73014053 |
| 70 | Osteolytic defects of the hand bones (HP:0009699) | 1.71254961 |
| 71 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.71254961 |
| 72 | Natal tooth (HP:0000695) | 1.70796568 |
| 73 | Arterial thrombosis (HP:0004420) | 1.70437555 |
| 74 | Dysostosis multiplex (HP:0000943) | 1.69034404 |
| 75 | Palmoplantar keratoderma (HP:0000982) | 1.68636887 |
| 76 | Abnormal hair laboratory examination (HP:0003328) | 1.68469037 |
| 77 | Ectropion (HP:0000656) | 1.68199995 |
| 78 | Selective tooth agenesis (HP:0001592) | 1.67906328 |
| 79 | Myocardial infarction (HP:0001658) | 1.67485895 |
| 80 | Sparse eyelashes (HP:0000653) | 1.64301345 |
| 81 | Curly hair (HP:0002212) | 1.61733441 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 1.60415353 |
| 83 | Episodic fever (HP:0001954) | 1.60115011 |
| 84 | Obstructive lung disease (HP:0006536) | 1.59772326 |
| 85 | Chronic obstructive pulmonary disease (HP:0006510) | 1.59772326 |
| 86 | Increased serum ferritin (HP:0003281) | 1.59657940 |
| 87 | Multifactorial inheritance (HP:0001426) | 1.59207545 |
| 88 | Joint swelling (HP:0001386) | 1.59020441 |
| 89 | Fragile skin (HP:0001030) | 1.57786446 |
| 90 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.56628824 |
| 91 | Joint hemorrhage (HP:0005261) | 1.56475921 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 1.55027332 |
| 93 | Broad face (HP:0000283) | 1.55002699 |
| 94 | Amyloidosis (HP:0011034) | 1.54922698 |
| 95 | Keratoconjunctivitis sicca (HP:0001097) | 1.53126955 |
| 96 | Flat acetabular roof (HP:0003180) | 1.51732699 |
| 97 | Upper limb muscle weakness (HP:0003484) | 1.50320370 |
| 98 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.48636171 |
| 99 | Abnormality of the salivary glands (HP:0010286) | 1.47340973 |
| 100 | Myositis (HP:0100614) | 1.47151703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.38315203 |
| 2 | EPHA2 | 3.40921168 |
| 3 | BMX | 3.12963463 |
| 4 | MST4 | 2.88112107 |
| 5 | MST1R | 2.53804230 |
| 6 | MYLK | 2.22890873 |
| 7 | BMPR2 | 2.14779363 |
| 8 | MAP3K3 | 2.10212681 |
| 9 | ZAP70 | 2.09872950 |
| 10 | BTK | 2.09775755 |
| 11 | SIK3 | 1.93222553 |
| 12 | PTK2B | 1.90243333 |
| 13 | MAP2K3 | 1.87554550 |
| 14 | SIK1 | 1.82449007 |
| 15 | CSF1R | 1.82219897 |
| 16 | EPHB1 | 1.76942237 |
| 17 | IRAK3 | 1.72244599 |
| 18 | EIF2AK1 | 1.71494816 |
| 19 | FGR | 1.67168448 |
| 20 | MET | 1.66296620 |
| 21 | EPHB2 | 1.61353566 |
| 22 | STK24 | 1.58138717 |
| 23 | TEC | 1.55573718 |
| 24 | CSK | 1.48905944 |
| 25 | BLK | 1.41114849 |
| 26 | MAPKAPK3 | 1.39570026 |
| 27 | LMTK2 | 1.36914829 |
| 28 | GRK6 | 1.36606935 |
| 29 | ILK | 1.36473563 |
| 30 | SYK | 1.31801480 |
| 31 | PTK2 | 1.27860974 |
| 32 | MAP3K6 | 1.27454503 |
| 33 | HCK | 1.27145771 |
| 34 | STK3 | 1.25915431 |
| 35 | MAP3K2 | 1.16435728 |
| 36 | ARAF | 1.13093163 |
| 37 | IRAK4 | 1.11936830 |
| 38 | TAOK1 | 1.11208841 |
| 39 | FER | 1.09746009 |
| 40 | PIK3CG | 1.05530876 |
| 41 | PRPF4B | 1.02998880 |
| 42 | TRIB3 | 1.01950184 |
| 43 | ERN1 | 1.01412117 |
| 44 | RIPK1 | 1.00900304 |
| 45 | FES | 0.98528346 |
| 46 | CDK12 | 0.96744517 |
| 47 | TAOK2 | 0.95363410 |
| 48 | IRAK1 | 0.94828938 |
| 49 | GRK5 | 0.92291934 |
| 50 | MAP3K1 | 0.91941283 |
| 51 | RET | 0.90308579 |
| 52 | STK10 | 0.89490447 |
| 53 | MAP3K11 | 0.89271986 |
| 54 | PAK4 | 0.89250779 |
| 55 | JAK3 | 0.88788329 |
| 56 | PKN2 | 0.87232065 |
| 57 | IKBKB | 0.86789483 |
| 58 | TTN | 0.85078841 |
| 59 | TRPM7 | 0.83090651 |
| 60 | PDGFRB | 0.81865678 |
| 61 | PIM2 | 0.80454980 |
| 62 | TESK2 | 0.80135668 |
| 63 | LRRK2 | 0.79746176 |
| 64 | MATK | 0.79457777 |
| 65 | FLT3 | 0.78442157 |
| 66 | PDPK1 | 0.76823614 |
| 67 | TGFBR2 | 0.76165516 |
| 68 | MAP3K12 | 0.75877095 |
| 69 | PAK1 | 0.71770975 |
| 70 | IRAK2 | 0.70052371 |
| 71 | STK38 | 0.69269990 |
| 72 | TAOK3 | 0.66816673 |
| 73 | SMG1 | 0.66685222 |
| 74 | MARK3 | 0.63514181 |
| 75 | YES1 | 0.61437121 |
| 76 | ERBB2 | 0.61027485 |
| 77 | KSR2 | 0.60340592 |
| 78 | CDC42BPA | 0.59780033 |
| 79 | MAP3K5 | 0.59329608 |
| 80 | PDK1 | 0.58560351 |
| 81 | LYN | 0.55080344 |
| 82 | MAP4K1 | 0.53773784 |
| 83 | TNK2 | 0.53013698 |
| 84 | TGFBR1 | 0.51895198 |
| 85 | DMPK | 0.51247083 |
| 86 | MAP3K9 | 0.51080011 |
| 87 | MAP2K1 | 0.49261243 |
| 88 | PTK6 | 0.48173479 |
| 89 | MAPKAPK2 | 0.47442774 |
| 90 | HIPK2 | 0.46549915 |
| 91 | TBK1 | 0.46486413 |
| 92 | ITK | 0.45617591 |
| 93 | TESK1 | 0.45493077 |
| 94 | MARK2 | 0.43963847 |
| 95 | SGK3 | 0.42691623 |
| 96 | PRKD1 | 0.42545397 |
| 97 | FYN | 0.40673983 |
| 98 | JAK1 | 0.40527004 |
| 99 | DAPK3 | 0.40314500 |
| 100 | JAK2 | 0.36312915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 3.38823226 |
| 2 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.50207123 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.26568796 |
| 4 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.11437404 |
| 5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69339516 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69116213 |
| 7 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.63927164 |
| 8 | Shigellosis_Homo sapiens_hsa05131 | 1.63545232 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.56405207 |
| 10 | Amoebiasis_Homo sapiens_hsa05146 | 1.55967422 |
| 11 | Focal adhesion_Homo sapiens_hsa04510 | 1.50350423 |
| 12 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.49638261 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.48859208 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.45221501 |
| 15 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42894457 |
| 16 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.42716428 |
| 17 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.41533001 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41394834 |
| 19 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.39699254 |
| 20 | Endocytosis_Homo sapiens_hsa04144 | 1.38979079 |
| 21 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.36272271 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.33439103 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.29357898 |
| 24 | Adherens junction_Homo sapiens_hsa04520 | 1.26268205 |
| 25 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.26015097 |
| 26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.25423554 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22078769 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21103604 |
| 29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.18692461 |
| 30 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.14844614 |
| 31 | Bladder cancer_Homo sapiens_hsa05219 | 1.14114857 |
| 32 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.12485569 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11796637 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.10657760 |
| 35 | Endometrial cancer_Homo sapiens_hsa05213 | 1.10174141 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.09359886 |
| 37 | Thyroid cancer_Homo sapiens_hsa05216 | 1.09019974 |
| 38 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.08318085 |
| 39 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05702747 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03947450 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.03345266 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.00563602 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00467465 |
| 44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00352222 |
| 45 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.00007746 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 0.99359859 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.99205869 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94219438 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93628418 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93453994 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92521806 |
| 52 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.87445282 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87368323 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86984223 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86933035 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.86119035 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85603068 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.82689297 |
| 59 | Legionellosis_Homo sapiens_hsa05134 | 0.82498881 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81984625 |
| 61 | Glioma_Homo sapiens_hsa05214 | 0.81530028 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.81504710 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.79669135 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78451012 |
| 65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77489719 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.76225187 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 0.75428085 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74345452 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73249520 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71573312 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71378826 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70140211 |
| 73 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68912459 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68591553 |
| 75 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.67975038 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67284740 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67016646 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65603033 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.65188966 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.63027415 |
| 81 | Measles_Homo sapiens_hsa05162 | 0.62077761 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61207509 |
| 83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61124713 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60885223 |
| 85 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60667833 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60332614 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59956945 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58935884 |
| 89 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58787613 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57688496 |
| 91 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57470160 |
| 92 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.56460390 |
| 93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56235375 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54815969 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54630917 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54289418 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53071817 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52717130 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.51940219 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51710823 |

